Calcitonin stimulating tests with Ca2+or pentagastrin are very useful, both for excluding an MTC when basal calcitoninis in the grey zone (15–50 ng/L) and for detecting residual disease or recurrence after surgery for MTC in patients with low basal levels [15]. The gene discussed is CALCA; the disease is medullary thyroid gland carcinoma.